While not FDA-approved for these conditions, studies have shown that GLP-1 agonists may also have additional health benefits, including: Reducing blood pressure Lowering cholesterol levels Reducing heart disease risk Improving fatty liver disease Side Effects & Risks GLP-1 medications may cause side effects, especially when first taking it
Researchers have also explored possible clinical applications for conditions like erythropoietic protoporphyria, where increased melanin may reduce light sensitivity
These factors highlight the need for larger, prospective studies with standardized collection of both objective and patient-reported outcomes to confirm and expand our findings
Ocular / Retinal Models Epithalon has also been tested in visual system research: In rodent models of retinal degeneration, Epithalon has been associated with preservation of retinal structure and improvement in electrophysiologic measures of retinal function in a subset of treated subjects
It's the only way to catch silent problems like elevated glucose, liver enzyme changes, or kidney stress before they become serious
Has discussion occurred with primary care physician